Single Slide Assessment: the future of molecular testing in lung cancer?

Conclusions: SSA is highly effective at preserving samples for molecular testing from EBUS-FNA. Therefore a single minimally invasive procedure offers access to novel immunotherapy, enhancing lung cancer care. With increasing emphasis on immunotherapy its value is likely to increase.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Lung Cancer Source Type: research